Lingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report one way it resets the stage to enable this common and often deadly cancer.
All news from Gastroenterology
Most people are not eager to talk about how to improve bowel movements, but researchers at The Ohio State University Wexner Medical Center found the solution to common bowel issues may be as simple as boosting your feet on a stool.
A study published today in the journal Gut shows that women with inflammatory bowel disease (IBD) are at greater risk of developing mental illness after giving birth compared to the overall population.
Among African-American adults undergoing a liver transplant to treat liver cancer, patients whose organ donor was also African-American lived significantly longer than those with a racially unmatched donor, report authors of a new study using national data. The study is published online as an "article in press" on the Journal of the American College of Surgeons website in advance of print publication.
Research carried out at the University of Adelaide shows that obese women lost more weight and improved their health by fasting intermittently while following a strictly controlled diet. The study, published in the journal Obesity, involved a sample of 88 women following carefully controlled diets over 10 weeks.
Probiotics can ease pain short-term in children with recurrent abdominal pain (RAP), according to a new report. One in four schoolchildren will experience RAP, a collective term for functional dyspepsia, irritable bowel syndrome (IBS), abdominal migraine, functional abdominal pain and functional abdominal pain syndrome – Dr. Tamsin Newlove-Delgado of the University of Exeter Medical School in the U.K. and her colleagues note in a "clinical evidence synopsis" in JAMA Pediatrics, online December 28.
Many veterans have strong preferences against colorectal cancer (CRC) screening cessation even when provided with information about the potential low benefit of screening, according to a study published online Dec. 7 in JAMA Network Open.
The current study was designed to investigate the effect of crocetin on the proliferation inhibition of colon cancer cells and the underlying mechanism. MTT assay showed inhibition of proliferation of colon cancer cells in a dose based manner by crocetin treatment. At 30 µM concentration of crocetin proliferation rate of colon cancer cells was reduced to 14% after 24 h.
Presently, there are no therapeutic options for unresectable hepatocellular carcinoma (u-HCC) patients who are intolerant to sorafenib or regorafenib failure. There have been no reports with detailed clinical findings of lenvatinib (LEN), a newly developed first-line tyrosine kinase inhibitor (TKI), obtained in real-world practice. We aimed to elucidate the therapeutic efficacy of LEN.
Telemedicine has been successfully used to provide inflammatory bowel disease (IBD) patients with health care services remotely via the implementation of information and communications technology, which uses safe and feasible apps that have been well accepted by patients in remission.